semaglutide step 5 - MG Semaglutide Weight Loss Program |

Intervention Seventy eligible participants were randomly assigned (1:1) to either semaglutide 2.4 mg weekly (Novo Nordisk) ( n = 35) or placebo (saline solution) ( n = 35), using self-administered once-weekly subcutaneous injections with identical-appearing pens

**Increases resting energy expenditure** -- your body burns more calories during normal daily activities, not just exercise 2

Nu cha la chn c n v no tin cy, qu khch c th la chn chng ti

Benefits: Accurate tracking of body changes over time

The first author claims that this resulted in a balanced dataset inclusive of the sample countries and further states that the imputation of missing values based on variablespecific trend will not change the result and large number of observations will produce more stable estimated coefficients